Skin melanoma remains one of the most aggressive and difficult to treat human malignancy, with an increasing incidence every year. Although surgical resection represents the best therapeutic approach, this is only feasible in cases of early diagnosis. Furthermore, the established malignancy is resistant to all therapeutic strategies employed so far, resulting in an unacceptable patient survival rate. Although the immune-mediated therapeutic approaches, based on anti-PD1 or anti-CTLA4, are very promising and under clinical trial experimentation, they could conceal not yet fully emerged pitfalls such as the development of autoimmune diseases. Therefore, alternative therapeutic approaches are still under investigation, such as the immunogenic cell death (ICD) process. Here we show that the lack of calreticulin translocation onto mouse melanoma cell membrane prevents the stimulation of an effective ICD response in vivo.

Giglio, P., Gagliardi, M., Bernardini, R., Mattei, M., Cotella, D., Santoro, C., et al. (2019). Ecto-Calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma. GENES AND IMMUNITY, 20(6), 509-513 [10.1038/s41435-018-0047-7].

Ecto-Calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma.

GIGLIO, PAOLA;GAGLIARDI, MARA;Bernardini R;Mattei M;Piacentini M;Corazzari M.
2019-01-01

Abstract

Skin melanoma remains one of the most aggressive and difficult to treat human malignancy, with an increasing incidence every year. Although surgical resection represents the best therapeutic approach, this is only feasible in cases of early diagnosis. Furthermore, the established malignancy is resistant to all therapeutic strategies employed so far, resulting in an unacceptable patient survival rate. Although the immune-mediated therapeutic approaches, based on anti-PD1 or anti-CTLA4, are very promising and under clinical trial experimentation, they could conceal not yet fully emerged pitfalls such as the development of autoimmune diseases. Therefore, alternative therapeutic approaches are still under investigation, such as the immunogenic cell death (ICD) process. Here we show that the lack of calreticulin translocation onto mouse melanoma cell membrane prevents the stimulation of an effective ICD response in vivo.
2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/06 - ANATOMIA COMPARATA E CITOLOGIA
English
Con Impact Factor ISI
Giglio, P., Gagliardi, M., Bernardini, R., Mattei, M., Cotella, D., Santoro, C., et al. (2019). Ecto-Calreticulin is essential for an efficient immunogenic cell death stimulation in mouse melanoma. GENES AND IMMUNITY, 20(6), 509-513 [10.1038/s41435-018-0047-7].
Giglio, P; Gagliardi, M; Bernardini, R; Mattei, M; Cotella, D; Santoro, C; Piacentini, M; Corazzari, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/207047
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 11
social impact